Cargando…

Racial Differences in the Cholesterol-Lowering Effect of Statin

Statin treatment to reduce low-density lipoprotein cholesterol (LDL-C) is associated with the prevention of cardiovascular events in Western patients. Similar results have been reported in studies conducted in Japan. However, the dose of statins and the degree of LDL-C reduction achieved with statin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naito, Ryo, Miyauchi, Katsumi, Daida, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225129/ https://www.ncbi.nlm.nih.gov/pubmed/27733728 http://dx.doi.org/10.5551/jat.RV16004

Ejemplares similares

Differences in Clinical Features in Patients with Acute Coronary Syndrome and Stroke: Japanese Multicenter Registry Results
por: Naito, Ryo, et al.
Publicado: (2018)

The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials
por: Daida, Hiroyuki, et al.
Publicado: (2019)

Early definite stent thrombosis with everolimus-eluting stents
por: Naito, Ryo, et al.
Publicado: (2015)

Impact of Lipoprotein (a) on Long-Term Outcomes in Patients with Coronary Artery Disease Treated with Statin After a First Percutaneous Coronary Intervention
por: Suwa, Satoru, et al.
Publicado: (2017)

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
por: Sakuma, Masashi, et al.
Publicado: (2022)

Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
por: Joo, Seung-Jae
Publicado: (2012)

RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2012)

Rapidly progressed aortic stenosis in a patient with previous diagnosis of polycythemia vera and post‐polycythemia vera myelofibrosis
por: Kiso, Shohei, et al.
Publicado: (2016)

Correction: RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin
por: Medina, Marisa W., et al.
Publicado: (2013)

Influence of Previous Statin Therapy on Cholesterol-Lowering Effect of Ezetimibe
por: Choi, Young Hwan, et al.
Publicado: (2014)

Statins redux: A re-assessment of how statins lower plasma cholesterol
por: Raghow, Rajendra
Publicado: (2017)

Cholesterol lowering for secondary prevention: What statin dose should we use?
por: Josan, Kiranbir, et al.
Publicado: (2007)

Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction
por: Shitara, Jun, et al.
Publicado: (2021)

Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
por: Ishii, Junnichi, et al.
Publicado: (2022)

Red cell distribution width predicts short- and long-term outcomes of acute congestive heart failure more effectively than hemoglobin
por: DAI, YUXIANG, et al.
Publicado: (2014)

High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study
por: Omote, Kazunori, et al.
Publicado: (2022)

Clinical Outcomes in Diabetic Patients Who Underwent Percutaneous Coronary Intervention during the Plain Old Balloon Angioplasty (POBA)-, Bare Metal Stents (BMS)- and Drug-eluting Stents (DES)-eras from 1984 to 2010
por: Naito, Ryo, et al.
Publicado: (2017)

Effects of fenofibrate on lipid profiles, cholesterol ester transfer activity, and in-stent intimal hyperplasia in patients after elective coronary stenting
por: Miyazaki, Tetsuro, et al.
Publicado: (2010)

Statins suppress cell-to-cell propagation of α-synuclein by lowering cholesterol
por: Min, Joo-Ok, et al.
Publicado: (2023)

Statins: Cholesterol guidelines and Indian perspective
por: Menon, Anil S., et al.
Publicado: (2015)

Cholesterol suppresses antimicrobial effect of statins
por: Haeri, Mohammad Reza, et al.
Publicado: (2015)

Development of Accelerated Coronary Atherosclerosis Model Using Low Density Lipoprotein Receptor Knock-Out Swine with Balloon Injury
por: Ogita, Manabu, et al.
Publicado: (2016)

Culprit Plaque Characteristics in Patients With Sleep‐Disordered Breathing Undergoing Percutaneous Coronary Intervention: An Intravascular Ultrasound Study
por: Wada, Hideki, et al.
Publicado: (2018)

Astragalus Polysaccharides Lowers Plasma Cholesterol through Mechanisms Distinct from Statins
por: Cheng, Yunjiu, et al.
Publicado: (2011)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Preliminary Pilot Study of Combined Effects of Physical Activity and Achievement of LDL-Cholesterol Target on Coronary Plaque Volume Changes in Patients with Acute Coronary Syndrome
por: Nishitani-Yokoyama, Miho, et al.
Publicado: (2020)

Effect of a PCSK9 inhibitor and a statin on cholesterol efflux capacity: A limitation of current cholesterol‐lowering treatments?
por: Ying, Qidi, et al.
Publicado: (2022)

Race‐Sex Differences in Statin Use and Low‐Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study
por: Gamboa, Christopher M., et al.
Publicado: (2017)

Elevated Circulating Levels of Inflammatory Markers in Patients with Acute Coronary Syndrome
por: Al Shahi, Hamad, et al.
Publicado: (2015)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
por: Grigore, Liliana, et al.
Publicado: (2008)

Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins
por: Reid, Patrick C, et al.
Publicado: (2007)

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

Effect of pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor α modular (SPPARMα), in atherosclerosis model using low density lipoprotein receptor knock-out swine with balloon injury
por: Konishi, Hirokazu, et al.
Publicado: (2020)

Successful Rotational Atherectomy for an Angulated Calcified Lesion in an Anomalous Right Coronary Artery Using the “Mother-and-Child” Technique
por: Ogita, Manabu, et al.
Publicado: (2018)

Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
por: Yi, Sang-Wook, et al.
Publicado: (2019)

Statins Lower Lipid Synthesis But Promote Secretion of Cholesterol-Enriched Extracellular Vesicles and Particles
por: Chen, Yundi, et al.
Publicado: (2022)

Genetically Guided Statin Therapy on Statin Perceptions, Adherence, and Cholesterol Lowering: A Pilot Implementation Study in Primary Care Patients
por: Li, Josephine H., et al.
Publicado: (2014)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?
por: Waters, David, et al.
Publicado: (2001)

290 The Correlation of Cholesterol Lowering Statin Drugs and Worsening Asthma Control in Mild Persistent Asthmatics
por: Nsouli, Safa
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_66dukr073kf6ec7um2ar2rpp6a